U.S. Markets
Eli Lilly (LLY) expects medicare beneficiaries will have access to discounted Lilly obesity medicines by July 1st 2026
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
